Second-Line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
Frontiers in Medicine - Switzerland
doi 10.3389/fmed.2017.00036
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 5, 2017
Authors
Publisher
Frontiers Media SA